A New Generic Favipiravir Version In India: A COVID-19 Early-Stage Treatment for the Lower-to-Middle-Income World?
TrialSite News,
Multiple varieties of Favipiravir continue to be marketed in India as a treatment for early-onset, mild-to-moderate COVID-19 in…